PHILADELPHIA, May 20 (Reuters) - Schering-Plough Corp said on Wednesday that Johnson & Johnson would seek to arbitrate an end to their Remicade drug partnership in the wake of Schering-Plough's planned merger with Merck & Co Inc.
PHILADELPHIA, May 20 (Reuters) - Schering-Plough Corp said on Wednesday that Johnson & Johnson would seek to arbitrate an end to their Remicade drug partnership in the wake of Schering-Plough's planned merger with Merck & Co Inc.
